CYTOSORBENTS CORP (CTSO): Hedge Fund Ownership & Smart Money Signals (Q4 2025)

CYTOSORBENTS CORP (CTSO)

48 + Investors. Track Smart Money conviction in CTSO. See who's accumulating, reducing, or initiating positions.

Smart Money Signals — CTSO

Based on 48 hedge funds · latest filing: 2025 Q4 · updated quarterly

📈

Buying streak — 2 quarters in a row

last 6Q

For 2 consecutive quarters, more hedge funds added CTSO than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

📊

High ownership — 92% of 3.0Y peak

92% of all-time peak

48 funds currently hold this stock — 92% of the 3.0-year high of 52 funds (reached 2023 Q1). Ownership is elevated but not yet at maximum concentration. Room to grow, but watch if the trend reverses.

〰️

Stable — ownership unchanged year-over-year

fund count last 6Q

The number of hedge funds holding CTSO is almost the same as a year ago (+0 funds, +0% change). No significant rush to buy or sell — institutional backing is holding steady.

🟡

Slight buying edge — 59% buying

22 buying15 selling

Last quarter: 22 funds bought or added vs 15 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.

➡️

Steady new buyers — ~8 new funds per quarter

new funds entering per quarter

Funds opening this position for the first time: 4 → 3 → 7 → 8. A stable flow of new institutional buyers suggests ongoing interest without signs of either acceleration or slowdown.

🔒

65% of holders stayed for 2+ years

■ 65% conviction (2yr+) ■ 23% medium ■ 12% new

31 out of 48 hedge funds have held CTSO for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.

💎

Buying through price weakness — shares +4%, value -30%

Value

-29%

+3%

Last quarter: funds added +4% more shares while total portfolio value only changed -30%. Institutions were buying while the price was falling — a high-conviction accumulation signal. They're deliberately loading up on the dip.

➡️

Steady discovery — ~8 new funds/quarter

10 → 4 → 3 → 7 → 8 new funds/Q

New funds entering each quarter: 4 → 3 → 7 → 8. Consistent flow of new institutional buyers without clear acceleration or slowdown.

🏛️

Deep conviction — 69% of holders stayed 2+ years

■ 69% veterans ■ 12% 1-2yr ■ 19% new

Of 48 current holders: 33 (69%) have held for over 2 years without selling. These are not momentum buyers — they have lived through drawdowns and stayed. A large veteran base acts as a stabilizing force during selloffs.

✅

Strong quality — 20% AUM from major funds

20% from top-100 AUM funds

14 of 48 holders rank in the top 100 by AUM, accounting for 20% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.

3.0

out of 10

Low Exit Risk

Exit risk score 3.0/10 — low institutional crowding. Ownership is below peak levels, holder base is relatively sticky, and buying momentum is positive.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Metric	All 13F Filers (2025 Q4)	Prior (2025 Q3)	Change
Funds Holding	48	46	4.35%
13F Shares	17M	16M	3.66%
Total Value	$11M	$15M	-29.59%
New Positions	8	7	+1
Increased Positions	15	14	+1
Closed Positions	5	3	+2
Reduced Positions	10	11	-1
Total Calls	0	1	-100.0%
Total Puts	0	0	-
PUT/CALL Ratio	0.0	0.0	Bullish

Metric

All 13F Filers (2025 Q4)

Prior (2025 Q3)

Change

Funds Holding

4.35%

13F Shares

17M

16M

3.66%

Total Value

$11M

$15M

-29.59%

New Positions

Increased Positions

Closed Positions

Reduced Positions

-1

Total Calls

-100.0%

Total Puts

PUT/CALL Ratio

0.0

Bullish

Institutional Holders (2026 Q1)

48 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in CTSO. Verified SEC 13F-HR filings.

FILTER:All New Added To Reduced No Change | Overweight >5% | SHOW: Active managers + show index funds

Top 11 institutional holders of CTSO — 2025 Q4 · Source: SEC Form 13F
#	Investor	% of Portfolio	Shares	Mkt Value
1	Skylands Capital, LLC	0.13%	1,707,498	$967K
2	Key Client Fiduciary Advisors, LLC	0.02%	78,457	$44K
3	Seelaus Asset Management LLC	0.01%	16,300	$9K
4	RITHOLTZ WEALTH MANAGEMENT	0.00%	27,443	$16K
5	Merit Financial Group, LLC	0.00%	15,297	$9K
6	Kestra Advisory Services, LLC	0.00%	28,200	$16K
7	Your Advocates Ltd., LLP	0.00%	250	—
8	Medallion Wealth Advisors, LLC	0.00%	45	—
9	FIFTH THIRD BANCORP	0.00%	3,082	$2K
10	Farther Finance Advisors, LLC	0.00%	6	—
11	SBI Securities Co., Ltd.	0.00%	1	—

Investor	Ownership History	% of Portfolio	Prev %	Rank	Conviction	Avg Buy Price	13F Score™ 3Y / 7Y	Sell Timing	Shares	Mkt Value	Change	Change %	Source	Quarter	Filed

Frequently Asked Questions — CYTOSORBENTS CORP (CTSO)

What does the Smart Money Trend signal show for CTSO?

Buying streak — 2 quarters in a row: For 2 consecutive quarters, more hedge funds added CTSO than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for CTSO?

Slight buying edge — 59% buying: Last quarter: 22 funds bought or added vs 15 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.

What is the fund quality score for CTSO holders?

Strong quality — 20% AUM from major funds: 14 of 48 holders rank in the top 100 by AUM, accounting for 20% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.

How long have hedge funds held CTSO?

65% of holders stayed for 2+ years: 31 out of 48 hedge funds have held CTSO for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Market Cap	--
Enterprise Value	--
Trailing P/E	--
Forward P/E	--
PEG Ratio (5yr expected)	--
Price/Sales (ttm)	--
Price/Book (mrq)	--
Enterprise Value/Revenue	--
Enterprise Value/EBITDA	--
Beta (5Y Monthly)	--
Short Ratio (Days to Cover)	--
Short % of Float	--

Profit Margin	--
Return on Assets (ttm)	--
Return on Equity (ttm)	--

Revenue (ttm)	--
Net Income Avi to Common (ttm)	--
Diluted EPS (ttm)	--
Total Cash (mrq)	--
Total Debt/Equity (mrq)	--
Levered Free Cash Flow (ttm)	--

CYTOSORBENTS CORP (CTSO)

Smart Money Signals — CTSO

Buying streak — 2 quarters in a row

High ownership — 92% of 3.0Y peak

Stable — ownership unchanged year-over-year

Slight buying edge — 59% buying

Steady new buyers — ~8 new funds per quarter

65% of holders stayed for 2+ years

Buying through price weakness — shares +4%, value -30%

Steady discovery — ~8 new funds/quarter

Deep conviction — 69% of holders stayed 2+ years

Strong quality — 20% AUM from major funds

Hedge Fund Ownership: CTSO

Market Analysis: CTSO

Analyst Price Targets

Analyst Recommendations

Stock Performance

Company Profile: CTSO

Hedge Fund Positioning: CTSO

Statistics: CTSO

Valuation Measures Data as of: --

Financial Highlights

Institutional Holders (2026 Q1)

Frequently Asked Questions — CYTOSORBENTS CORP (CTSO)

Welcome to 13Foresight!